FDA Rejects Psychedelic MDMA to Treat PTSD

Published on August 9, 2024

Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions. Drugmaker Lykos…

Read Full Article (External Site)